Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,550.50
(
-0.93%
)
US TECH 100
23,245.20
(
-1.25%
)
Dow Jones
46,247.68
(
-0.90%
)
Brent Oil
106.65
(
-0.40%
)
Bitcoin
68,152.69
(
-1.02%
)
News Focus
News Focus
Post# of 257368
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122853
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 84495

Monday, 04/12/2010 8:49:51 PM

Monday, April 12, 2010 8:49:51 PM

Post# of 257368
Does anyone think this IGIV survey was unbiased?

http://finance.yahoo.com/news/GamunexR-is-the-Preferred-prnews-1535189131.html?x=0&.v=1

In the survey, conducted online by Harris Interactive on behalf of Talecris, neurologists selected Gamunex over four times more often than all other available liquid IGIV therapies, with a statistically significant margin (p<0.05).

LOL re the p-value.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today